Who
D. Gordon Strickland
Director
Company insider
Files Form 4 as: Director, MetaVia; CEO, President & Director, Ampex Corp /de/.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 16 Feb 2007
- Last trade
- 8 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 8 Jun 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —17,186 at $0.00 | filing |
| 8 Jun 2026filed 8 Jun 2026 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —17,186 at $0.00 | filing |
| 30 Jun 2025filed 1 Jul 2025 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —28,147 at $0.00 | filing |
| 7 Jun 2024filed 7 Jun 2024 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —5,051 at $0.00 | filing |
| 27 Jul 2023filed 28 Jul 2023 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —87,500 at $0.00 | filing |
| 27 Jul 2023filed 28 Jul 2023 | MTVA MetaViaBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | MTVA MetaViaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Jan 2022filed 2 Feb 2022 | MTVA MetaViaoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 16 Feb 2007filed 21 Feb 2007 | Ampex Corp /de/option or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.